









| 货号 | HV974016 |
|---|---|
| 品牌 | abinScience |
| 描述 | Atezolizumab (HV974016) is a research-grade recombinant antibody targeting CD1. Produced in mammalian cells with native-like glycosylation.
Highlights
Resources
|
| 种属反应性 | Human |
| 应用 | ELISA, Bioactivity: FCM, Functional assay, Research in vivo |
| 宿主 | Human |
| 克隆类型 | Monoclonal |
| 同种型 | IgG1-kappa |
| 经测试应用 | FCM |
| 靶标 | B7 homolog 1, B7-H1, B7H1, CD274, PD-L1, PDCD1 ligand 1, PDCD1L1, PDCD1LG1, PDL1, Programmed cell death 1 ligand 1, Programmed death ligand 1 |
| 内毒素水平 | < 10 EU/mg |
| 纯度 | >95% as determined by SDS-PAGE. |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| Accession号 | Q9NZQ7 |
| 状态 | Liquid |
| 保存溶液 | 0.01M PBS pH 7.4. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
| 稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 别名 | MPDL3280A, RG7446, 1380723-44-3 |
| 背景 | Programmed cell death 1 ligand 1 (CD274/PD-L1) is a ~33 kDa protein. Plays a critical role in induction and maintenance of immune tolerance to self. As a ligand for the inhibitory receptor PDCD1/PD-1, modulates the activation threshold of T-cells and limits T-cell effector response. Through a yet unknown activating receptor, may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10). Can also act as a transcription coactivator: in response to hypoxia, translocates into the nucleus via its interaction with phosphorylated STAT3 and promotes transcription of GSDMC, leading to pyroptosis. CD274 is the therapeutic target of atezolizumab (Tecentriq) and durvalumab (Imfinzi). _x005F_x000D_ _x005F_x000D_1. Freeman, GJ. et al. (2000) The Journal of experimental medicine 192, 1027-34. PMID: 11015443 _x005F_x000D_
_x005F_x000D_
2. Mezzadra, R. et al. (2017) Nature 549, 106-110. PMID: 28813410 _x005F_x000D_
_x005F_x000D_
3. Burr, ML. et al. (2017) Nature 549, 101-105. PMID: 28813417 _x005F_x000D_
_x005F_x000D_
4. Huang, X. et al. (2019) Cancer immunology research 7, 1580-1590. PMID: 31399419 _x005F_x000D_
_x005F_x000D_
5. Kennedy, A. et al. (2023) The EMBO journal 42, e111556. PMID: 36727298 _x005F_x000D_
_x005F_x000D_
6. Dong, H. et al. (1999) Nature medicine 5, 1365-9. PMID: 10581077 _x005F_x000D_
_x005F_x000D_
7. Hou, J. et al. (2020) Nature cell biology 22, 1264-1275. PMID: 32929201 _x005F_x000D_ |
| Note | For research use only. Not suitable for clinical or therapeutic use. |

SEC-HPLC detection for Research Grade Atezolizumab.

Detects CD274/PD-L1/B7-H1 in indirect ELISAs.

SDS-PAGE for Research Grade Atezolizumab

Flow-cytometry using anti-human CD274 antibody. Untransfected cells (blue Histogram) and Transfected cells (Yellow Histogram) were stained with an anti-human CD274 monoclonal antibody (Catalog HV974016) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a Goat Anti-Human IgG H&L Polyclonal Antibody, FITC (abinScience: HF690414) and cells analysed on a NovoCyte Flow Cytometer.

Flow-cytometry using FITC anti-human CD274 antibody. MDA-MB-231 cells were stained with an irrelevant antibody (Blue Histogram) or an FITC anti-human CD274 monoclonal antibody (Catalog: HV974016, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.











24小时产品查询

扫一扫关注我们

专属渠道经理